The Cyp2b6 Gene Polymorphism and Phenotypic Correlation of Efavirenz-Based Combination Therapy Among the Niger Delta Ethnic Population: Implications in Modern Pharmacogenomics

References

• Oetjens MT, Denny JC, Ritchie MD. Assessment of a pharmacogenomics marker panel in a polypharmacy population identified from electronic medical records. Pharmacogenomics. 2013;14(7):735–744. doi:10.2217/pgs.13.64
   PubMed Web of Science ®Google Scholar
• Leeder JS. Pharmacogenetics and pharmacogenomics. Pediatr Clin North Am. 2001;48(3):765–781. doi:10.1016/S0031-3955(05)70338-2
   PubMed Web of Science ®Google Scholar
• Li J, Bluth MH. Pharmacogenomics of drug-metabolizing enzymes and transporters: implications for cancer therapy. Pharmgenomics Pers Med. 2011;4:11–33. doi:10.2147/PGPM.S18861
   PubMedGoogle Scholar
• Wijnen PA, Op den Buijsch RA, Drent M. Review article: the prevalence and clinical relevance of cytochrome P450 polymorphisms. Aliment Pharmacol Ther. 2007;26(Suppl 2):211–219. doi:10.1111/j.1365-2036.2007.03490.x
   PubMed Web of Science ®Google Scholar
• Smith BT, editor. Concepts in Immunology and Immunotherapeutics. 4th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2008:143.
   Google Scholar
• Barret J, Joshi AS, Chai M, Ludden TM, Fiske WD, Pieniaszek HJ. Population pharmacokinetic meta-analysis with efavirenz. Int J Clin Pharmacol Ther. 2002;40:507–519. doi:10.5414/CPP40507
   PubMed Web of Science ®Google Scholar
• Marzolini C, Telenti A, Descosterd LA, Grueb G, Biolazz J, Buclin T. Efavirenz plasma level can predict treatment failure and central nervous system side effects in HIV-1 infected patients. AIDS. 2001;5:71–75. doi:10.1097/00002030-200101050-00011
   Web of Science ®Google Scholar
• Klein K, Lang T, Saussele T, et al. Genetic variability of CYP2B6 in populations of Africa and Asian origin: Allele frequencies, novel functional variations and possible implications for anti-HIV therapy with efavirenz. Pharmacogent Genomics. 2005;15:861–873. doi:10.1097/01213011-200512000-00004
   PubMed Web of Science ®Google Scholar
• Ebeshi BU, Bolaji OO, Masimirembwa CM. Cytochrome P450 2D6 (CYP2D6) genotype and phenotype determination in the Nigeria population. Asian J Pharm Health Sci. 2011;1(2):47–54.
   Google Scholar
• Padh H. Pharmacogenetics: polymorphism and genotype-phenotype correlation of drug response in Indian population. Mol Cytogenet. 2014;7:I52. doi:10.1186/1755-8166-7-S1-I52
   PubMedGoogle Scholar
• UNAIDS. Fact sheet; Latest statistics on the status of AIDS epidemic [UNAIDS]. Available from: www.unaids.org. Accessed March 16, 2018.
   Google Scholar
• WHO. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: World Health Organization; 2015. Available from: http://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en. Accessed January 6, 2022.
   Google Scholar
• Csajka C, Marzolini C, Fattinger K, Decosterd LA, Fellay J, Telenti A. Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection. Clin Pharmacol Ther. 2003;73:20–30. doi:10.1067/mcp.2003.22
   PubMed Web of Science ®Google Scholar
• Saiki R, Scharf S, Faloona F, et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985;230(4732):1350–1354. doi:10.1126/science.2999980
   PubMed Web of Science ®Google Scholar
• National Centre for Biotechnology Information (NCBI). Polymorphism, Restriction Fragment Length [MAJR] in PubMed. 8600 Rockville Pike, Bethesda MD, 20894 USA: U.S. National Library of Medicine; 2017.
   Google Scholar
• Clark J. High-Performance Liquid Chromatography - HPLC. Available from: https://www.chemguide.co.uk/analysis/chromatography/hplc.html. Accessed January 6, 2022. 2016.
   Google Scholar
• Bunu SJ, Otele D, Alade T, Dodoru RT. Determination of serum DNA purity among patients undergoing antiretroviral therapy using NanoDrop-1000 spectrophotometer and polymerase chain reaction. Biomed Biotechnol Res J. 2020;4:214–219. doi:10.4103/bbrj.bbrj_68_20
   Google Scholar
• Rotger M, Colombo S, Furrer H, Bleiber G, Buclin T, Lee BL. Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients. Pharmacogenet Genomics. 2005;15:1–5. doi:10.1097/01213011-200501000-00001
   PubMedGoogle Scholar
• National Centre for Biotechnology Information (NCBI) databases. Available from: http://blast.ncbi.nlm.nih.gov/Blast.cgi. Accessed August 25, 2021.
   Google Scholar
• Aryal S. Polymerase chain reaction (PCR), principle, procedure, types, applications, and animation. Microbiology info.com; [ updated July 6, 2018].
   Google Scholar
• Ebeshi BU, Bolaji OO, Oluka M, Edebi VN, Soyinka JO, Guantai A. Simple reversed-phase high-performance liquid chromatographic estimation of the antiretroviral agent Efavirenz from human plasma. Br J Pharm Res. 2014;4(1):145–157. doi:10.9734/BJPR/2014/4123
   Google Scholar
• Deshpande N, Sharanya V, Murthy HV, et al. Rapid and ultra-rapid metabolizers with CYP2C19*17 polymorphism do not respond to standard therapy with proton pump inhibitors. Meta Gene. 2016;9:159–164. doi:10.1016/j.mgene.2016.06.004
   PubMed Web of Science ®Google Scholar
• García-González X, Cabaleiro T, Herrero MJ, McLeod H, López-Fernández LA. Clinical implementation of pharmacogenetics. Drug Metab Pers Ther. 2016;31(1):9–16. doi:10.1515/dmpt-2015-0031
   PubMedGoogle Scholar
• Nemaura T, Nhachi C, Masimirembwa C. Impact of gender, weight and CYP2B6 genotype on efavirenz exposure in patients on HIV/AIDS and TB treatment: implications for individualizing therapy. Afr J Pharm Pharmacol. 2012;6(29):2188–2193.
   Google Scholar
• Thelma A, Samuel BJ. Genetic testing and non-chemotherapeutic management of prostate cancer. Int J Pharm Sci Drug Anal. 2021;1(1):12–17.
   Google Scholar
• Mehlotra RK, Bockarie MJ, Zimmerman PA. CYP2B6 983T>C polymorphism is prevalent in West Africa but absent in Papua New Guinea: implications for HIV/AIDS treatment. Br J Clin Pharmacol. 2007;64(3):391–395. doi:10.1111/j.1365-2125.2007.02884.x
   PubMed Web of Science ®Google Scholar